Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Retained Earnings (2024 - 2025)

Historic Retained Earnings for RenovoRx (RNXT) over the last 2 years, with Q3 2025 value amounting to -$58.4 million.

  • RenovoRx's Retained Earnings fell 2345.75% to -$58.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.4 million, marking a year-over-year decrease of 2345.75%. This contributed to the annual value of -$50.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, RenovoRx's Retained Earnings is -$58.4 million, which was down 2345.75% from -$55.5 million recorded in Q2 2025.
  • RenovoRx's 5-year Retained Earnings high stood at -$42.5 million for Q1 2024, and its period low was -$58.4 million during Q3 2025.